Early Detection and Interception of Cancer: Current Practice Recommendations and Novel Emerging Approaches
- Continuing Education
Elevate your approach to cancer prevention with this dynamic course offering practical guidance on current screening practices, management of high-risk populations, and the integration of emerging early detection technologies into clinical care.
- Live Online or In Person
Participants may attend either virtually or in person.
Joseph B. Martin Conference Center | 77 Avenue Louis Pasteur, Boston, MA 02115
$500
This is the standard price, for a full list of profession pricing see below.
View All
Continuing Education
Earn up to:
5.25 AMA PRA Category 1 Credit(s) ™
5.25 ANCC contact hours
View All
One Day
Please view the Schedule for a full description of the program.
On This Page
Overview
We will provide a comprehensive review of current cancer screening guidelines, provide guidance regarding high-risk populations and their management, educate regarding emerging technologies for early cancer detection, and provide referral pathways for complex patients.
Learning Objectives
- Identify and implement current cancer screening guidelines, with a focus on early detection and intervention for high-risk populations, and provide recommendations for managing these patients.
- Identify and establish appropriate referral pathways for patients with pre-malignant conditions requiring specialized care.
- Evaluate emerging technologies in cancer detection and assess their application for early detection of cancer.
Developed and Offered By:
Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by Dana-Farber Cancer Institute.
Who Should Participate
Specialty Physicians, Physician Assistants, Nurse Practitioners, Primary Care Physicians, and Genetic Counselors.
Schedule
All agenda sessions are in Eastern Time.
Wednesday, September 16, 2026
Welcome and Kick Off
8:30-8:45 am
Advancing Early Detection and interception from the Perspective of the Primary Care Physician
8:45-9:05 am
Q&A
9:05-9:15 am
Genetics 101: Genetic Testing for Inherited Cancer Predisposition in Your Practice
9:15-9:30 am
Management of Hereditary Cancer Predisposition in Your Practice
9:30-9:45 am
The PREMM plus Model / An Easy Way to Identify At Risk Individuals in Your Practice
9:45-10:00 am
Management of DCIS (Ductal Carcinoma in Situ) and Other Breast Cancer Precursors
10:00-10:15 am
Screening and Early Detection of Gynecologic Malignancies
10:15-10:30 am
Q&A
10:30-10:45 am
Break
10:45-11:00 am
Screening and Early Detection of Dermatologic Malignancies
11:00-11:15 am
Unexplained Cytopenia - When to Consider Clonal Hematopoiesis and Myelodysplastic Syndrome (MDS)
11:15-11:30 am
Intercepting Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma
11:30-11:45 am
Q&A
11:45 am-12:00 pm
Lunch Break
12:00-12:45 pm
Precursors to Head & Neck, Oral Cancers, and Management
12:45-1:00 pm
Management of IPMNs, Barrett's Esophagus and other Precursors to GI Cancer
1:00-1:20 pm
Screening and Early Detection of Lung Cancer
1:20-1:40 pm
Screening and Early Detection of Genitourinary Cancers
1:40-2:00 pm
Q&A
2:00-2:15 pm
Break
2:15-2:30 pm
Implementation of Cancer Screening and Early Detection in the Community
2:30-2:45 pm
Multi-Cancer Early Detection Tests – Ready for Prime Time?
2:45-3:00 pm
Whole Body Imaging for Screening and Early Detection of Cancer – Promises and Pitfalls
3:00-3:15 pm
Panel Discussion: Looking to the Future of Early Detection and Interception
3:15-3:30 pm
Networking Reception
3:30-4:30 pm
Faculty
Harvard Medical School Continuing Education attracts the best and brightest faculty from all around the world. As a student in this course, you’ll have access to outstanding course directors and faculty.
Course Directors
Elizabeth (Betsy) O’Donnell, MD
Course Director
- Director, Multi-Cancer Early Detection Clinic, Dana-Farber Cancer Institute
- Assistant Professor of Medicine, Harvard Medical School
Sapna Syngal, MD, MPH
Course Director
- Director, Centers for Early Detection and Interception, Solid Tumors, Dana-Farber Cancer Institute
- Director of Research, Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute
- Professor of Medicine, Harvard Medical School
Colleen Feltmate, MD
Co-Director, Center for Early Detection and Interception, Gynecologic Tumors, Dana-Farber Cancer Institute
Director, Minimally Invasive Surgery in Gynecologic Oncology, Brigham and Women's Hospital
Assistant Professor of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School
Karina Franca
Genetic Counselor, Cancer Genetics and Prevention
Irene Ghobrial, MD
Senior Vice President for Experimental Medicine, Dana-Farber Cancer Institute
Director of the Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute
Professor of Medicine, Harvard Medical School
Kayoll Gyan, PhD, RN
Associate Director of The Phyllis F. Cantor Center of Research in Nursing and Patient Care Services, Dana-Farber Cancer Institute
Glenn Hanna, MD
Director, Center for Cancer Therapeutic Innovation (Early Drug Development Program), Dana-Farber Cancer Institute
Director, Center for Salivary and Rare Head and Neck Cancers, Dana-Farber Cancer Institute
Associate Professor of Medicine, Harvard Medical School
Elizabeth Housman, MD
Instructor of Medicine, Harvard Medical School
Nicole Leboeuf, MD, MPH
Vice Chair, Department of Dermatology, Dana-Farber Cancer Institute
Director, Cutaneous Oncology, Dana-Farber Cancer Institute
Associate Professor of Dermatology, Harvard Medical School
Vinod Nambudiri MD, MBA
Program Director, Harvard Dermatology Residency Program
Associate Professor, Harvard Medical School
Elizabeth (Betsy) O'Donnell, MD
Director, Multi-Cancer Early Detection Clinic, Dana-Farber Cancer Institute
Associate Professor of Medicine, Harvard Medical School
Anuradha Ramaswamy, MD
Huma Rana, MD, MPH
Clinical Director, Cancer Genetics and Prevention, Dana-Farber Cancer Institute
Assistant Professor of Medicine, Harvard Medical School
Nicolette Rodriguez, MD, MPH
Director, Center for Early Detection and Interception, Gastrointestinal Tumors, Dana-Farber Cancer Institute
Instructor in Medicine, Harvard Medical School
Michael Rosenthal, MD, PhD
Assistant Director of Radiology, Dana-Farber/Brigham and Women's Hospital Pancreas and Biliary Tumor Center
Assistant Professor of Radiology, Harvard Medical School
Emily Stern Gatof, MD
Oncologist, Breast Oncology and Cancer Genetics and High Risk, Cancer Center at Beth Israel Deaconess Medical Center
Instructor of Clinical Medicine, Harvard Medical School
Sapna Syngal, MD, MPH
Director, Centers for Early Detection and Interception, Solid Tumors, Dana-Farber Cancer Institute Professor of Medicine
Dr. Bicky Thapa, MD, MS, FACP
Director, Center for Early Detection and Interception, Genitourinary Tumors, Dana-Farber Cancer Institute
Instructor in Medicine, Harvard Medical School
Lachelle Weeks, MD, PhD
Director, Center for Early Detection and Interception, CHIP, Dana-Farber Cancer Institute
Assistant Professor of Medicine, Harvard Medical School
Location Information
Venue
All in person sessions will be held at:
Joseph B. Martin Conference Center
77 Avenue Louis Pasteur
Boston, MA 02115
Learners are also invited to attend virtually.
Hotel Reservations
Hotel Commonwealth
500 Commonwealth Avenue
Boston, MA 02215
www.hotelcommonwealth.com
Sean.Minnihan@hotelcommonwealth.com
Complete Your Registration
Started a registration? Log in to enroll today.
Request Information
Interested in learning more about this program? Sign up for details.
Course Fees
Registration Details
You may register through our secure online environment and will receive an email confirmation upon receipt of your payment.
Prices include CME credit, electronic syllabus, some recordings for up to 9 days after course has ended, and refreshments at breaks and breakfast.
At the end of the registration process, a $10 non-refundable processing fee will be added to your registration.
| Role | Course Fee |
|---|---|
| Physician (MD/DO) | $500 |
| Nurse (RN/APRN) | $250 |
| PA | $250 |
| Psychologist | $250 |
| Resident/Fellow | $250 |
| Social Worker | $250 |
| Allied Health Professional / Other | $250 |
Accreditation
The Harvard Medical School designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Harvard Medical School designates this live activity for a maximum of 5.25 ANCC contact hours.
Harvard Medical School has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialists (UEMS). Additional information regarding this agreement may be found on the Union of European Medical Specialists website.
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.